Abelacimab versus Rivaroxaban in Atrial Fibrillation | NEJM
Quick Take Video Summary from The New England Journal of Medicine — Abelacimab versus Rivaroxaban in Atrial Fibrillation
Related Articles
Darier’s Sign in Solitary Mastocytoma | NEJM
A previously healthy 10-month-old girl presented with an intermittently itchy and swollen skin lesion on the neck. When rubbed, the lesion became edematous with a…
Acquired Osteomalacia Associated with Autoantibodies against PHEX | NEJM
This letter reports an association between acquired osteomalacia and autoantibodies against PHEX (phosphate-regulating endopeptidase X-linked), which may be termed autoimmune osteomalacia.
Sport-Related Concussion | NEJM
Sport-related concussion is a mild traumatic brain injury that resolves within weeks, but symptoms may persist beyond 1 month. Light physical activity and graduated aerobic…
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis | NEJM
For decades, poor treatment options and low-quality evidence plagued care for patients with rifampin-resistant tuberculosis. The advent of new drugs to treat tuberculosis and enhanced…
Tirzepatide for Congenital Generalized Lipodystrophy | NEJM
Two patients with congenital generalized lipodystrophy type 1 due to a variant in AGPAT2 (c.589-2A→G) who had been receiving insulin and metreleptin were switched to…
CRISPR-Based Therapy for Hereditary Angioedema | NEJM
Hereditary angioedema is a rare genetic disease characterized by severe and unpredictable swelling attacks. NTLA-2002 is an in vivo gene-editing therapy that is based on…
Continuation versus Interruption of Oral Anticoagulation during TAVI | NEJM
One third of patients undergoing transcatheter aortic-valve implantation (TAVI) have an indication for oral anticoagulation owing to concomitant diseases. Interruption of oral anticoagulation durin…
Tirzepatide for Congenital Generalized Lipodystrophy | NEJM
Two patients with congenital generalized lipodystrophy type 1 due to a variant in AGPAT2 (c.589-2A→G) who had been receiving insulin and metreleptin were switched to…
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity | NEJM
Obesity increases the risk of heart failure with preserved ejection fraction. Tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor…
Evolving Epidemiology of Mpox in Africa in 2024 | NEJM
For decades after the identification of mpox in humans in the Democratic Republic of Congo (DRC) in 1970, the disease was largely confined to the…